Picosulfate Sodium API molecular structure visualization
Local Action API

Picosulfate Sodium

A precisely controlled, prodrug-based stimulant laxative heavily utilized worldwide for highly predictable pre-procedural bowel evacuation dynamics.

CAS Number

10040-45-6

Formula

C₁₈H₁₃NNa₂O₈S₂

Mol. Weight

481.41 g/mol

Grade

BP / EP / USP

COA & DMF Ready
Pharmacopeial Compliant
USFDA Regulated Market Ready
Prodrug Colonic Cleavage

Product Overview

Picosulfate Sodium formally operates as a highly specific prodrug compound. It requires explicit hydrolysis by colonic bacteria to break down into its active metabolite, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM). This profoundly localized biological mechanism explicitly stimulates the colonic mucosa to heavily increase peristaltic contractions.

As a global commercial trading leader, Jay Overseas strictly emphasizes sourcing this highly essential API directly from certified facilities maintaining complex regulatory profiles. It functions globally as the unquestionable foundation for chronic constipation therapeutics and exhaustive pre-colonoscopy bowel cleansing regimens globally.

Local Intestinal Activation

Targets the exact required motility structures bypassing major blood barriers safely.

Predictable Action Profiling

Strict pharmacological control specifically tailored for exact pre-procedural timelines.

API Snapshot

CAS Number10040-45-6
Molecular FormulaC₁₈H₁₃NNa₂O₈S₂
GradeUSP / EP / BP
FormatLaxative Prodrug
StorageProtect from light/heat
Request Compliance Data →

Colonic Mechanism of Action

01

Prodrug Administration

Delivered cleanly as a triphenylmethane derivative, the chemical safely passes the upper gastrointestinal structures with zero premature breakdown.

02

Bacterial Hydrolysis

Upon entering the colon, the inactive API vigorously undergoes explicit bacterial hydrolysis entirely driven by resident lower colonic microbiota.

03

Motility Secretion

The resulting active BHPM metabolite forcefully binds to the enteric nervous system, prompting highly elevated intestinal motility and critical bowel evacuation.

Therapeutic Targets

Therapeutic Applications

01

Diagnostic Bowel Prep

Highly aggressive, clean bowel preparation standardly utilized preceding colonoscopies.

02

Colorectal Surgical Prep

Strict pre-operative bowel evacuation safely executed directly prior to complex colorectal surgical events.

03

Radiological Diagnostics

Supports highly sensitive radiological examinations heavily demanding an absolutely clean bowel matrix.

04

Chronic Constipation

Measured, long-term pharmacological treatment pathways for recurring chronic constipation profiles.

Competitive Edge

Clinical Advantages & Value Proposition

Its highly explicit mechanism isolates systemic breakdown risks, making it uniquely reliable for exceptionally vulnerable diagnostic preparation protocols.

Predictable, fully manageable onset of action naturally triggering within 6-12 hours

Radically minimal systemic absorption due to its localized activation in the lower colon

Fails to induce harmful electrolyte imbalances when rigidly kept at established therapeutic dosing ranges

Highly adaptable physical framework capable of formulation into standard tablets, solutions, or pediatric drops

Analytical Data

Detailed BP Grade Specifications

DMF Verification Available | Full Global Regulatory Support

Sr.Criteria PhaseGlobal Specification Limits
1DescriptionWhite to slightly pink crystalline powder
2SolubilityFreely soluble in water, sparingly soluble in alcohol
3IdentificationIR spectrum conforms to reference standard (BP)
4pH (1% solution)8.5 – 10.0
5Loss on DryingNot more than 10.0%
6Related Substances (HPLC)BHPM: NMT 0.5% | Total impurities: NMT 1.5%
7Sulfated Ash20.0% – 24.0%
8Heavy MetalsNMT 20 ppm
9Assay (Dried, HPLC)98.0% – 102.0%
10Microbial LimitsAerobic: NMT 1000 CFU/g | E.coli/Salmonella: Absent
Trading Excellence

Why Partner with Jay Overseas

Ensuring your supply chains function under flawlessly audited compliance parameters globally.

Global Supply Networks

Consistent global availability backed tightly by efficient international logistics to 45+ countries through our extensive pharmaceutical trading nexus.

Pharmaceutical Grade Purity

Consistent high-purity API production featuring uncompromisingly stringent impurity control limits backed by deeply transparent analytical batch documentation.

Uncompromising Compliance

API exclusively sourced from USFDA DMF filed and WHO-GMP certified facilities maintaining formal compliance tightly to major BP, EP, and USP standards.

Export Level Packaging

Double LDPE internal barriers protected inherently by robust HDPE or thick fiber drum encasements. Export-worthy customs labeling fully administered.

Storage Execution

Must rigidly store in environments natively below 25°C (77°F). Extensively protect all exposures precisely from sudden light and latent local moisture elements.

Commercial Shelf Life

Guarantees formal 36-month stability thresholds mapped rigorously according precisely to formal ICH Q3C baseline validation guidelines.

Construct Your Dosage Portfolio

Reach out to our expert commercial teams today for dispatch of testing batches, customizable packaging protocols, and immediate provision of our expansive DMF documentation.

Legal Disclaimer: Picosulfate Sodium API rigorously functions as an active biological raw material. It is exclusively engineered strictly for professional manufacturing compilation entities only. Usage falls entirely within highly specific clinical importation compliances. Formulations explicitly remain strictly non-consumable directly.